Department of Ophthalmology, Fukuoka University Chikushi Hospital, Chikusino-shi, Fukuoka, 818-8502, Japan.
Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):799-804. doi: 10.1007/s00417-010-1301-5. Epub 2010 Feb 5.
The purpose of this study was to determine whether vitrectomy alters the angiogenic profile in the vitreous of eyes with proliferative diabetic retinopathy (PDR).
We measured the levels of angiopoietin-2, HGF, bFGF, PDGF, TIMP-1, and TIMP-2 by sandwich enzyme linked immunosorbent assay (ELISA) in vitreous samples from 27 eyes of 26 patients with PDR before pars plana vitrectomy (without IOL implantation) and in 12 fluid samples from 12 patients with PDR obtained during an IOL implantation 3.5 to 9 (mean 4.9) months after an earlier vitrectomy. The levels of these factors were also measured in 12 vitreous samples obtained from 12 eyes that had undergone epiretinal membrane (ERM) or macular hole (MH) surgeries.
The mean vitreous levels of both angiopietin-2 (103 pg/ml) and HGF (1091 pg/ml) in the sample from eyes with PDR collected at the time of the IOL implantation were significantly lower than in those collected before the vitrectomy (P < 0.01). On the other hand, the changes in the levels of TIMP-1 and TIMP-2 were both not significant after vitrectomy.
The significant decrease of angiopietin-2 and HGF in the vitreous fluid after vitrectomy suggests that vitrectomy shifts the eye towards an anti-angiogenic environment.
本研究旨在确定玻璃体切割术是否会改变增生性糖尿病视网膜病变(PDR)眼中玻璃体的血管生成谱。
我们通过夹心酶联免疫吸附试验(ELISA)测量了 26 例 27 只 PDR 眼玻璃体样本中血管生成素-2(Angiopoietin-2)、HGF、bFGF、PDGF、TIMP-1 和 TIMP-2 的水平,这些样本来自于在进行玻璃体切割术(无 IOL 植入)前的玻璃体,并测量了 12 例 PDR 患者在 IOL 植入后 3.5 至 9 个月(平均 4.9 个月)期间的 12 例玻璃体样本中的这些因子的水平。这些因子的水平也在 12 例接受了视网膜前膜(ERM)或黄斑裂孔(MH)手术的眼中的玻璃体样本中进行了测量。
在 IOL 植入时取自 PDR 眼的玻璃体样本中,Angiopoietin-2(103 pg/ml)和 HGF(1091 pg/ml)的平均玻璃体水平明显低于玻璃体切割术前(P < 0.01)。另一方面,玻璃体切割术后 TIMP-1 和 TIMP-2 的水平变化均不显著。
玻璃体切割术后玻璃体中 Angiopoietin-2 和 HGF 的显著下降表明玻璃体切割术使眼睛向抗血管生成环境转变。